- Home
- IZM vs FGEN Comparison
IZM vs FGEN Comparison
Compare IZM & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- FGEN
- Stock Information
- Founded
- IZM 2011
- FGEN 1993
- Country
- IZM China
- FGEN United States
- Employees
- IZM N/A
- FGEN N/A
- Industry
- IZM Consumer Electronics/Video Chains
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- IZM Consumer Discretionary
- FGEN Health Care
- Exchange
- IZM Nasdaq
- FGEN Nasdaq
- Market Cap
- IZM 28.7M
- FGEN 33.5M
- IPO Year
- IZM 2023
- FGEN 2014
- Fundamental
- Price
- IZM $2.58
- FGEN $7.26
- Analyst Decision
- IZM
- FGEN Strong Buy
- Analyst Count
- IZM 0
- FGEN 1
- Target Price
- IZM N/A
- FGEN $250.00
- AVG Volume (30 Days)
- IZM 31.7K
- FGEN 74.7K
- Earning Date
- IZM 07-25-2025
- FGEN 08-05-2025
- Dividend Yield
- IZM N/A
- FGEN N/A
- EPS Growth
- IZM N/A
- FGEN N/A
- EPS
- IZM N/A
- FGEN N/A
- Revenue
- IZM $180,553,977.00
- FGEN $6,996,000.00
- Revenue This Year
- IZM N/A
- FGEN N/A
- Revenue Next Year
- IZM N/A
- FGEN N/A
- P/E Ratio
- IZM N/A
- FGEN N/A
- Revenue Growth
- IZM N/A
- FGEN N/A
- 52 Week Low
- IZM $1.18
- FGEN $4.50
- 52 Week High
- IZM $3.19
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- IZM 59.08
- FGEN 60.54
- Support Level
- IZM $2.50
- FGEN $5.37
- Resistance Level
- IZM $2.74
- FGEN $5.73
- Average True Range (ATR)
- IZM 0.10
- FGEN 0.49
- MACD
- IZM -0.00
- FGEN 0.27
- Stochastic Oscillator
- IZM 73.68
- FGEN 83.80
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.